Dimenhydrinate Tablet
Product Images NDC 0904-6772

1 FDA label image from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Dimenhydrinate (NDC 0904-6772). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1006-major Label (1006 12bb Label)

1006-major Label (1006 12bb Label)
Dimenhydrinate 50 mg oral tablets under the brand name Driminate by Major Pharmaceuticals. The carton contains 12 tablets and highlights the use for nausea, dizziness, and vomiting from motion sickness. The label specifies the product as an antiemetic and includes directions and drug facts panels. The design features a yellow and red color scheme with prominent product and labeler information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.